NASDAQ:SLS
SELLAS Life Sciences Group, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.sellaslifesciences.comipo date
Mar 12, 2008
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus